{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:57:08Z","timestamp":1779357428881,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008493","name":"V\u00e4in\u00f6 ja Laina Kiven S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008368","name":"Suomen Tuberkuloosin Vastustamisyhdistyksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010125","name":"Jalmari ja Rauha Ahokkaan S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013506","name":"Kuopion Seudun Hengityss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03218-z","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:02:43Z","timestamp":1724950963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determinants of cough-related quality of life in interstitial lung diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Eeva","family":"Saari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Mononen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannele","family":"Hasala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Nurmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu-Pekka","family":"Kettunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna","family":"Suoranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lappi-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Kaarteenaho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Purokivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki Olavi","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"2","key":"3218_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","unstructured":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3218_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/resp.14493","volume":"28","author":"T Fujisawa","year":"2023","unstructured":"Fujisawa T, Akiyama N, Morita T, Koyauchi T, Matsuda Y, Mori M, et al. Palliative care for interstitial lung disease: a nationwide survey of pulmonary specialists. Respirology. 2023;28(7):659\u201368.","journal-title":"Respirology"},{"issue":"1","key":"3218_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12890-023-02476-7","volume":"23","author":"E Saari","year":"2023","unstructured":"Saari E, Mononen M, Hasala H, L\u00e4tti A, Kaulamo J, Nurmi H, et al. Characteristics of idiopathic pulmonary fibrosis -associated cough. A case-control study. BMC Pulm Med. 2023;23(1):179.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"3218_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1440-1843.2011.01996.x","volume":"16","author":"CJ Ryerson","year":"2011","unstructured":"Ryerson CJ, Abbritti M, Ley B, Elicker BM, Jones KD, Collard HR. Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology. 2011;16(6):969\u201375.","journal-title":"Respirology"},{"issue":"5","key":"3218_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/resp.12989","volume":"22","author":"IN Glaspole","year":"2017","unstructured":"Glaspole IN, Chapman SA, Cooper WA, Ellis SJ, Goh NS, Hopkins PM, et al. Health-related quality of life in idiopathic pulmonary fibrosis: data from the Australian IPF Registry. Respirology. 2017;22(5):950\u20136.","journal-title":"Respirology"},{"issue":"6","key":"3218_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1183\/09031936.00187410","volume":"38","author":"A Nardi","year":"2011","unstructured":"Nardi A, Brillet PY, Letoumelin P, Girard F, Brauner M, Uzunhan Y, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368\u201373.","journal-title":"Eur Respir J"},{"key":"3218_CR8","doi-asserted-by":"publisher","first-page":"3808206","DOI":"10.1155\/2019\/3808206","volume":"2019","author":"E Kovacova","year":"2019","unstructured":"Kovacova E, Vysehradsky R, Kocan I, Plevkova J, Buday T. Retrospective study of factors potentially influencing occurrence of Cough in Slovak patients with Sarcoidosis. Can Respir J. 2019;2019:3808206.","journal-title":"Can Respir J"},{"key":"3218_CR9","doi-asserted-by":"crossref","unstructured":"Lan NSH, Moore I, Lake F. Understanding cough in interstitial lung disease: a cross-sectional study on the adequacy of treatment. InternMedJ. 2020;(Journal Article).","DOI":"10.1111\/imj.14837"},{"key":"3218_CR10","doi-asserted-by":"publisher","first-page":"121578","DOI":"10.1155\/2013\/121578","volume":"2013","author":"L Pan","year":"2013","unstructured":"Pan L, Liu Y, Sun R, Fan M, Shi G. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study. Clin Dev Immunol. 2013;2013:121578.","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"3218_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12890-018-0738-x","volume":"18","author":"K Rajala","year":"2018","unstructured":"Rajala K, Lehto JT, Sutinen E, Kautiainen H, Myll\u00e4rniemi M, Saarto T. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life. BMC Pulm Med. 2018;18(1):172.","journal-title":"BMC Pulm Med"},{"key":"3218_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.hrtlng.2023.05.013","volume":"61","author":"AEM Bloem","year":"2023","unstructured":"Bloem AEM, Houben-Wilke S, Mostard RLM, Stoot N, Janssen DJA, Franssen FME, et al. Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls. Heart Lung. 2023;61:136\u201346.","journal-title":"Heart Lung"},{"issue":"1","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12931-019-1020-3","volume":"20","author":"M Kreuter","year":"2019","unstructured":"Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, et al. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry. Respir Res. 2019;20(1):59.","journal-title":"Respir Res"},{"issue":"3","key":"3218_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.chest.2022.03.025","volume":"162","author":"J Lee","year":"2022","unstructured":"Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, et al. Cough-specific quality of Life predicts Disease Progression among patients with interstitial lung disease: data from the Pulmonary Fibrosis Foundation Patient Registry. Chest. 2022;162(3):603\u201313.","journal-title":"Chest"},{"issue":"Journal Article","key":"3218_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-9974-7-2","volume":"7","author":"RM Jones","year":"2011","unstructured":"Jones RM, Hilldrup S, Hope-Gill BD, Eccles R, Harrison NK. Mechanical induction of cough in idiopathic pulmonary fibrosis. Cough. 2011;7(Journal Article):2\u20132.","journal-title":"Cough"},{"issue":"8","key":"3218_CR16","first-page":"995","volume":"168","author":"BD Hope-Gill","year":"2003","unstructured":"Hope-Gill BD, Hilldrup S, Davies C, Newton RP, Harrison NK. A study of the cough reflex in idiopathic pulmonary fibrosis. AmJRespirCritCare Med. 2003;168(8):995\u20131002.","journal-title":"AmJRespirCritCare Med"},{"key":"3218_CR17","unstructured":"Harrison NK. Cough, sarcoidosis and idiopathic pulmonary fibrosis: Raw nerves and bad vibrations. Cough [Internet]. 2013;9(1). https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-84874523402&doi=10.1186%2f1745-9974-9-9&partnerID=40&md5=8cb1f1176b89ae71e1ed6b0c57590b9c"},{"issue":"Journal Article","key":"3218_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1745-9974-10-3","volume":"10","author":"MB Scholand","year":"2014","unstructured":"Scholand MB, Wolff R, Crossno PF, Sundar K, Winegar M, Whipple S, et al. Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype. Cough. 2014;10(Journal Article):3\u20133. eCollection 2014.","journal-title":"Cough"},{"issue":"8","key":"3218_CR19","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/resp.13116","volume":"22","author":"P Saunders","year":"2017","unstructured":"Saunders P, Maher TM. Cough in fibrotic lung disease: an unresolved challenge. Respirology. 2017;22(8):1491\u20132.","journal-title":"Respirology"},{"issue":"1","key":"3218_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11739-018-1960-5","volume":"14","author":"E Bargagli","year":"2018","unstructured":"Bargagli E, Di Masi M, Perruzza M, Vietri L, Bergantini L, Torricelli E, et al. The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis. Intern Emerg Med. 2018;14(1):39\u201343.","journal-title":"Intern Emerg Med"},{"key":"3218_CR21","doi-asserted-by":"publisher","first-page":"106922","DOI":"10.1016\/j.rmed.2022.106922","volume":"200","author":"M Mononen","year":"2022","unstructured":"Mononen M, Saari E, Hasala H, Kettunen HP, Suoranta S, Nurmi H, et al. Risk factors of clinically significant complications in transbronchial lung cryobiopsy: a prospective multi-center study. Respir Med. 2022;200:106922.","journal-title":"Respir Med"},{"issue":"6","key":"3218_CR22","first-page":"788","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. AmJRespirCritCare Med. 2011;183(6):788\u2013824.","journal-title":"AmJRespirCritCare Med"},{"issue":"5","key":"3218_CR23","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723\u20138.","journal-title":"Chest"},{"issue":"4","key":"3218_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thorax.58.4.339","volume":"58","author":"SS Birring","year":"2003","unstructured":"Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339\u201343.","journal-title":"Thorax"},{"key":"3218_CR26","doi-asserted-by":"crossref","unstructured":"Jones PW, Quirk FH, Baveystock CM. The St George\u2019s respiratory questionnaire. Respir Med. 1991;85 Suppl B:25\u201331; discussion 33\u201337.","DOI":"10.1016\/S0954-6111(06)80166-6"},{"issue":"1","key":"3218_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12931-017-0503-3","volume":"18","author":"T Furukawa","year":"2017","unstructured":"Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, et al. The St. George\u2019s respiratory questionnaire as a prognostic factor in IPF. Respir Res. 2017;18(1):18.","journal-title":"Respir Res"},{"key":"3218_CR28","doi-asserted-by":"crossref","unstructured":"Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K et al. Performance of the St George\u2019s respiratory questionnaire in patients with connective tissue disease-associated interstitial lung disease. Respirology. 2018.","DOI":"10.1111\/resp.13293"},{"key":"3218_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","volume":"187","author":"Raj AA","year":"2009","unstructured":"Raj AA, Pavord DI, Birring SS. Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire? Handb Exp Pharmacol. 2009;187:311\u201320.","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"3218_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/thoraxjnl-2020-216351","volume":"77","author":"EM Landt","year":"2022","unstructured":"Landt EM, \u00c7olak Y, Nordestgaard BG, Lange P, Dahl M. Risk and impact of chronic cough in obese individuals from the general population. Thorax. 2022;77(3):223\u201330.","journal-title":"Thorax"},{"key":"3218_CR31","doi-asserted-by":"publisher","first-page":"106792","DOI":"10.1016\/j.rmed.2022.106792","volume":"195","author":"MR Schaeffer","year":"2022","unstructured":"Schaeffer MR, Kumar DS, Assayag D, Fisher JH, Johannson KA, Khalil N, et al. Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILD. Respir Med. 2022;195:106792.","journal-title":"Respir Med"},{"key":"3218_CR32","doi-asserted-by":"publisher","first-page":"106600","DOI":"10.1016\/j.rmed.2021.106600","volume":"188","author":"BC Frye","year":"2021","unstructured":"Frye BC, Potasso L, Farin E, Fichtner U, Birring S, M\u00fcller-Quernheim J, et al. Abnormal FeV1 and body mass index are associated with impaired cough-related quality of life in sarcoidosis patients. Respir Med. 2021;188:106600.","journal-title":"Respir Med"},{"issue":"2","key":"3218_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.chest.2021.03.058","volume":"160","author":"MR Anderson","year":"2021","unstructured":"Anderson MR, Kim JS, Allison M, Giles JT, Hoffman EA, Ding J, et al. Adiposity and Interstitial Lung Abnormalities in Community-Dwelling adults: the MESA Cohort Study. Chest. 2021;160(2):582\u201394.","journal-title":"Chest"},{"issue":"3","key":"3218_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.chest.2019.10.011","volume":"157","author":"JS Kim","year":"2020","unstructured":"Kim JS, Anderson MR, Podolanczuk AJ, Kawut SM, Allison MA, Raghu G, et al. Associations of serum adipokines with subclinical interstitial lung disease among Community-Dwelling adults: the multi-ethnic study of atherosclerosis (MESA). Chest. 2020;157(3):580\u20139.","journal-title":"Chest"},{"key":"3218_CR35","doi-asserted-by":"publisher","first-page":"106309","DOI":"10.1016\/j.rmed.2021.106309","volume":"178","author":"M Baqir","year":"2021","unstructured":"Baqir M, Vasirreddy A, Vu AN, Moua T, Chamberlain AM, Frank RD, et al. Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a population-based, case-control study. Respir Med. 2021;178:106309.","journal-title":"Respir Med"},{"key":"3218_CR36","doi-asserted-by":"crossref","unstructured":"Joshua J, Pathak C, Zifan A, Chen R, Malhotra A, Mittal RK. Selective dysfunction of the crural diaphragm in patients with chronic restrictive and obstructive lung disease. Neurogastroenterol Motil. 2023;e14699.","DOI":"10.1111\/nmo.14699"},{"issue":"5","key":"3218_CR37","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.chest.2021.11.008","volume":"161","author":"A Comes","year":"2022","unstructured":"Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, et al. Association of BMI and change in Weight with mortality in patients with fibrotic interstitial lung disease. Chest. 2022;161(5):1320\u20139.","journal-title":"Chest"},{"issue":"2","key":"3218_CR38","doi-asserted-by":"publisher","first-page":"e232558","DOI":"10.1148\/radiol.232558","volume":"310","author":"AA Bankier","year":"2024","unstructured":"Bankier AA, MacMahon H, Colby T, Gevenois PA, Goo JM, Leung ANC, et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 2024;310(2):e232558.","journal-title":"Radiology"},{"issue":"2","key":"3218_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5858\/arpa.2020-0543-RA","volume":"146","author":"Y Rosen","year":"2022","unstructured":"Rosen Y. Pathology of Granulomatous Pulmonary diseases. Arch Pathol Lab Med. 2022;146(2):233\u201351.","journal-title":"Arch Pathol Lab Med"},{"key":"3218_CR40","doi-asserted-by":"crossref","unstructured":"Kumar R, Spalgais S, Ranga V. Hypersensitivity pneumonitis: clinical, radiological and pathological profile of 103 patients from North India. Monaldi Arch Chest Dis. 2020;90(3).","DOI":"10.4081\/monaldi.2020.1307"},{"issue":"1","key":"3218_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1465-9921-11-156","volume":"11","author":"C Dagnell","year":"2010","unstructured":"Dagnell C, Grunewald J, Kramar M, Haugom-Olsen H, Elmberger GP, Eklund A, et al. Neurotrophins and neurotrophin receptors in pulmonary sarcoidosis - granulomas as a source of expression. Respir Res. 2010;11(1):156.","journal-title":"Respir Res"},{"issue":"1","key":"3218_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1752-699X.2009.00143.x","volume":"4","author":"HO Koskela","year":"2010","unstructured":"Koskela HO, Purokivi MK, Romppanen J. Neurotrophins in chronic cough: association with asthma but not with cough severity. Clin Respir J. 2010;4(1):45\u201350.","journal-title":"Clin Respir J"},{"issue":"8","key":"3218_CR43","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3348\/kjr.2020.1082","volume":"22","author":"T Franquet","year":"2021","unstructured":"Franquet T, Franks TJ, Galvin JR, Marchiori E, Gim\u00e9nez A, Mazzini S, et al. Non-infectious granulomatous lung disease: imaging findings with pathologic correlation. Korean J Radiol. 2021;22(8):1416\u201335.","journal-title":"Korean J Radiol"},{"issue":"2","key":"3218_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000330900","volume":"158","author":"I Cerveri","year":"2012","unstructured":"Cerveri I, Cazzoletti L, Corsico AG, Marcon A, Niniano R, Grosso A, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol. 2012;158(2):175\u201383.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"3218_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1164\/rccm.200612-1759OC","volume":"177","author":"KM Antoniou","year":"2008","unstructured":"Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med. 2008;177(2):190\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3218_CR46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/resp.13084","volume":"22","author":"JZ Cheng","year":"2017","unstructured":"Cheng JZ, Wilcox PG, Glaspole I, Corte TJ, Murphy D, Hague CJ, et al. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology. 2017;22(8):1592\u20137.","journal-title":"Respirology"},{"issue":"5","key":"3218_CR47","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1183\/13993003.01369-2015","volume":"47","author":"A Sinha","year":"2016","unstructured":"Sinha A, Lee KK, Rafferty GF, Yousaf N, Pavord ID, Galloway J, et al. Predictors of objective cough frequency in pulmonary sarcoidosis. Eur Respir J. 2016;47(5):1461\u201371.","journal-title":"Eur Respir J"},{"key":"3218_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1477-7525-10-4","volume":"10","author":"FF Berkhof","year":"2012","unstructured":"Berkhof FF, Boom LN, ten Hertog NE, Uil SM, Kerstjens HAM, van den Berg JWK. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012;10:4.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3218_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00160508","volume":"34","author":"MP Murray","year":"2009","unstructured":"Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34(1):125\u201331.","journal-title":"Eur Respir J"},{"issue":"1","key":"3218_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.resinv.2020.06.005","volume":"59","author":"S Takao","year":"2021","unstructured":"Takao S, Tabusadani M, Yamane K, Kakuta T, Kuroyama Y, Mori K, et al. Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease? Respir Investig. 2021;59(1):120\u20135.","journal-title":"Respir Investig"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03218-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03218-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03218-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:25:20Z","timestamp":1724963120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03218-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03218-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols were approved by the Research Ethics Committee of the Northern Savo Hospital district (statement 80\/2014), and Tampere University Hospital (R15149). The studies were conducted in compliance with the Declaration of Helsinki (as revised in 2013). A written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Competing interests: E.S. congress travel costs from Sanofi Finland, Orion Pharma and Astra Zeneca, virtual congress costs from Roche, owns personal stocks from Orion Pharma Ltd, Board member of Finnish allergology- and immunology association outside the submitted work. M.M. personal consulting fee and lecture fee from Boehringer Ingelheim and Astra Zeneca, congress travel and admission cost from Boehringer Ingelheim outside the submitted work. H.H. personal lecture fee from Boehringer Ingelheim outside the submitted work. H.N. personal lecture fees from Boehringer Ingelheim, Duodecim and Nordic Health Group, congress travel costs from Boehringer Ingelheim, and Duodecim outside the submitted work. S.S. owns personal stocks from Merck & Co, CRISPR Therapeutics, 3\u00a0M, Organon & Co, Pfizer outside the submitted work. H-P.K. personal lecture fee from Finnish thoracic radiologist society outside the submitted work. R.K. personal consulting fee from Boehringer Ingelheim and MSD and lecture fee from Boehringer Ingelheim, virtual congress travel costs from Novartis, Board member of the Finnish Lung Health Association and the Finnish Medical Foundation outside the submitted work. MP: personal lecture fee from Boehringer Ingelheim and Hengitysyhdistys, advisory board member of Boehringer Ingelheim outside the submitted work. HOK: personal lecture fee from Boehringer Ingelheim, MSD, Chiesi Pharma, owns personal stocks from Orion Pharma Ltd outside the submitted work. E.L-B. declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"427"}}